News Links
Press Releases and Product Information for October 27, 2021
LifeScan launches digital diabetes management platform vTv Therapeutics Inc. (NASDAQ: VTVT) Announces Positive TTP399 Mechanistic Study Data on Type 1 Diabetes Patients Diabetes Injection Pens Market – Rising incidence of diabetes is expected to propel the demand for insulin injection pens New Agreement Places DreaMed Diabetes’s Innovative AI Platform in Leading U.S. Children’s Hospital LovedBy and Dexom announce partnership to aid adolescent patients with diabetes
Read MorePopular Press News for October 27, 2021
Diabetes patients’ DIY solutions are still the standard of care Express Scripts to prefer first interchangeable biosimilar insulin Augustine woman running NYC Marathon for Type 1 Diabetes awareness This child turned her health scare into art that rocks Hybrid closed-loop therapy beneficial for children with type 1 diabetes Ten years later, young man with Type 1 diabetes runs for – not away from – his life ‘Push the Bar Higher’: New Statement on Type 1 Diabetes in Adults
Read MoreResearch News for October 27, 2021
Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis (Full text HTML, PDF) Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes Immunoreactive Trypsinogen and Free Carnitine Changes on Newborn Screening after Birth in Patients Who Develop Type 1 Diabetes (Full text HTML, PDF) The Genetics of Diabetes: What We Can Learn from Drosophila Type 1 Diabetes Mellitus and the First Trimester Placenta: Hyperglycemia-Induced Effects on Trophoblast Proliferation, Cell Cycle Regulators, and Invasion […]
Read MoreDaily Care News for October 27, 2021
Next-generation artificial pancreas boosts time in range for children with diabetes Patterns of insulin therapy and insulin daily doses in children and adolescents with type 1 diabetes in Germany Safety and glycemic outcomes during the MiniMed™ Advanced Hybrid Closed-Loop system pivotal trial in adolescents and adults with type 1 diabetes Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe Association between HbA1c levels on adverse pregnancy outcomes during pregnancy in type 1 diabetic patients Non-alcoholic fatty liver disease: A patient guideline (Full text HTML, PDF) […]
Read MoreLegislative and Policy News for October 20, 2021
Thank you to everyone who supported our pre-budget submission call to action but it’s only the beginning California SB-97 Pupil health: type 1 diabetes information: parent notification N.C. Diabetes Registry Registration Form
Read MoreCeliac News for October 20, 2021
Investigation of Protein and Epitope Characteristics of Oats and Its Implications for Celiac Disease (Full text HTML, PDF) Non-celiac gluten sensitivity as a rare cause of growth retardation in children: a case series study (Full text HTML, PDF) Adult celiac disease with persistent IBS-type symptoms: a pilot study of an adjuvant FODMAP diet Human Leucocyte Antigen Genotyping in Celiac Disease: Reasons for Inappropriate Use Gastrointestinal microbiome and gluten in celiac disease (Full text HTML, PDF) Evaluation of Burden and Anxiety in Caregivers of Patients with Pediatric Celiac Disease in the COVID-19 Pandemic (Full text HTML, PDF) Self-reported Wheat Sensitivity in […]
Read MorePress Releases and Product Information for October 20, 2021
People with diabetes can now view Dexcom CGM data on their Garmin smartwatch or cycling computer Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes
Read MorePopular Press News for October 20, 2021
Taking care of your feet if you have diabetes This hidden condition has left half of sufferers feeling ‘unsupported’ through the pandemic A single patient is producing insulin after treatment with Vertex’s new diabetes cell therapy Several beta cell receptors could explain link between COVID-19, new-onset diabetes Opinion: My insulin hasn’t changed, but the price has risen more than 600%
Read More